Hematologic toxicity profile and efficacy of [225Ac]Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer
Loading...
Date
Authors
Lawal, Ismaheel Opeyemi
Morgenstern, Alfred
Vorster, Mariza
Knoesen, Otto
Mahapane, Johncy
Hlongwa, Khanyisile N.
Maserumule, Letjie C.
Ndlovu, Honest
Reed, Janet D.
Popoola, Gbenga O.
Journal Title
Journal ISSN
Volume Title
Publisher
Springer
Abstract
Please read abstract in the article.
Description
Keywords
Targeted alpha therapy, Superscan, Skeletal metastases, Prostate cancer, Hematologic toxicity, Metastatic castration-resistant prostate cancer (mCRPC), Actinium-225-labeled prostate-specific membrane antigen ([225Ac]Ac-PSMA-617)
Sustainable Development Goals
Citation
Lawal, I.O., Morgenstern, A., Vorster, M. et al. Hematologic toxicity profile and efficacy of [225Ac]Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging 49, 3581–3592 (2022). https://doi.org/10.1007/s00259-022-05778-w.